** Shares of Belgian radiation therapy and
radiopharmaceuticals equipment company Ion Beam Applications
IBAB.BR up 6% after it announces a contract with Benebion for
a Rhodotron accelerator in Mexico
** The contract size, typically around 8.5 mln euros to 11
mln euros ($8.98 mln to $11.62 mln), shows positive commercial
momentum for IBA - ING analyst David Vagman
** Order intake development is yet to be seen to fully
comprehend the situation - brokerage
** KBC Securities sees returning momentum for IBA's
industrial solutions, pointing to the second Rhodotron contract
signed in November
** KBC keeps its "buy" rating due to revived demand in
industrial solutions and underlying radiopharma growth trends
** IBA shares are leading the Belgium Mid Cap index .BELMC
($1 = 0.9466 euros)
(Reporting by Gianluca Lo Nostro)
((gianluca.lonostro@thomsonreuters.com;))